Prospective payment system
Prospective payment system (PPS) is a method of reimbursement in which Medicare payment is made based on a predetermined, fixed amount. The payment amount for a particular service is derived based on the classification system of that service (for example, diagnosis-related groups for inpatient hospital services).
Overview[edit | edit source]
PPS is the primary method of payment for all acute care inpatient services for Medicare beneficiaries. Under PPS, hospitals are paid a set fee for treating patients in a single DRG category, no matter what the actual costs for the care turn out to be.
History[edit | edit source]
The prospective payment system was introduced by the U.S. Congress in 1983 as part of the Social Security Amendments, in an effort to change the incentives for healthcare providers and to control the rapidly escalating costs of healthcare.
Methodology[edit | edit source]
The PPS uses a classification system called diagnosis-related groups (DRGs). Under the DRG system, each patient is categorized into a group based on their diagnosis, surgical procedures, age, sex, and other factors. Each DRG has a payment weight assigned to it, based on the average resources used to treat Medicare patients in that DRG.
Impact[edit | edit source]
The introduction of the PPS has led to significant changes in the hospital industry and in the way patient care is delivered. It has been associated with a decrease in inpatient hospital stays and an increase in outpatient surgery.
Criticism[edit | edit source]
Critics of the PPS argue that it incentivizes hospitals to discharge patients as soon as possible in order to maximize profits. This can lead to inadequate care and higher readmission rates.
See also[edit | edit source]
- Diagnosis-related group
- Medicare (United States)
- Healthcare reform in the United States
- Healthcare in the United States
References[edit | edit source]
Prospective payment system Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD